SCHEMBL22084384

SCHEMBL22084384

Oc1ccc(Cn2cnc3c(S)ncnc32)cc1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ DAPK1 P53355 1/20 0.50
▸ ADORA2A P29274 1/20 0.50
▸ PI4KA P42356 1/20 0.50
▸ PI4K2B Q8TCG2 1/20 0.50
▸ PI4K2A Q9BTU6 1/20 0.50
▸ PI4KB Q9UBF8 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.48
▸ FGFR1 P11362 5/20 0.46
▸ FGFR4 P22455 5/20 0.46
▸ HTT P42858 1/20 0.46
▸ PDE10A Q9Y233 1/20 0.45
▸ PDE4A P27815 1/20 0.44
▸ PDE4B Q07343 1/20 0.44
▸ PDE4C Q08493 1/20 0.44
▸ PDE4D Q08499 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22084386 0.85 ADORA2A (0.47) DAPK1ADORA2API4KAPI4K2BPI4K2A
SCHEMBL22084387 0.79 PDE10A (0.48) DAPK1ADORA2API4KAPI4K2BPI4K2A
SCHEMBL22084385 0.77 PDE10A (0.46) DAPK1ADORA2API4KAPI4K2BPI4K2A
SCHEMBL22085121 0.77 PDE10A (0.46) DAPK1ADORA2API4KAPI4K2BPI4K2A
SCHEMBL22085120 0.76 DAPK1 (0.42) DAPK1ADORA2API4KAPI4K2BPI4K2A
SCHEMBL22084425 0.76 ADORA2A (0.47) DAPK1ADORA2API4KAPI4K2BPI4K2A
SCHEMBL22084396 0.76 ADORA2A (0.41) DAPK1ADORA2API4KAPI4K2BPI4K2A
SCHEMBL22084395 0.76 ADORA2A (0.41) DAPK1ADORA2API4KAPI4K2BPI4K2A
SCHEMBL22085122 0.76 FGFR1 (0.43) DAPK1ADORA2API4KAPI4K2BPI4K2A
SCHEMBL22085119 0.74 PDE10A (0.42) DAPK1ADORA2API4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020117938-A1 PRODRUGS OF ANTI-CANCER AND ANTI-AUTOIMMUNE DISEASES THERAPEUTIC AGENTS, AND METHODS OF MAKING AND USE THEREOF UNIVERSITY OF MARYLAND, BALTIMORE (US) 2020-06-11 — — WO disclosed
Send feedback